AcipHex (Page 9 of 9)

Rabeprazole Sodium DR 20 mg tabs

Label ImageLabel Image
ACIPHEX rabeprazole sodium tablet, delayed release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68151-3834(NDC:62856-243)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
RABEPRAZOLE SODIUM (RABEPRAZOLE) RABEPRAZOLE SODIUM 20 mg
Inactive Ingredients
Ingredient Name Strength
CARNAUBA WAX
CROSPOVIDONE
DIACETYLATED MONOGLYCERIDES
ETHYLCELLULOSES
HYDROXYPROPYL CELLULOSE (TYPE H)
HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST)
MAGNESIUM STEARATE
MANNITOL
PROPYLENE GLYCOL
SODIUM HYDROXIDE
SODIUM STEARYL FUMARATE
TALC
TITANIUM DIOXIDE
FERRIC OXIDE YELLOW
FERRIC OXIDE RED
Product Characteristics
Color YELLOW (yellow) Score no score
Shape ROUND (ROUND) Size 8mm
Flavor Imprint Code ACIPHEX;20
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68151-3834-3 1 TABLET, DELAYED RELEASE in 1 PACKAGE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020973 08/19/1999
Labeler — Carilion Materials Management (079239644)
Establishment
Name Address ID/FEI Operations
Carilion Materials Management 079239644 REPACK (68151-3834)

Revised: 08/2016 Carilion Materials Management

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.